Lucentis® (Ranibizumab) For Treating Visual Impairment Due To Diabetic Macular Oedema, Study Shows New Evidence

2012/09/06
By
RESTORE extension study demonstrates fully maintained initial vision gains with an average of 13.9 ranibizumab 0...

Full Story →

Archives